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ABSTRACT
Introduction: The pathogenicity of Staphylococcus aureus depends on various bacterial surface components and extracellular proteins. S. aureus 
expresses a variety of virulence factors, including Panton–Valentine leukocidin (pvl). pvl is a cytotoxin produced by S. aureus that causes leukocyte 
destruction and tissue necrosis. Despite the presumed importance of pvl as a virulence factor, few data are available on its prevalence among S. aureus 
isolates in our area.
Objectives: This study was aimed to determine the association between mecA gene and virulence genes such as pvl gene in strains of S. aureus and to 
determine the prevalence of the pvl gene in S. aureus isolates using the polymerase chain reaction (PCR) technique.
Methods: A total of 200 non-repeated, confirmed clinical isolates of S. aureus were used from various departments. Cefoxitin (30 ug) disc diffusion 
method was used as phenotypic method for detection of methicillin-resistant S. aureus (MRSA). We used PCR amplification to test for the pvl and mecA 
gene in S. aureus isolates.
Results: Of 200 strains of S. aureus isolated in our hospital, 60 (30%) were identified as MRSA based on cefoxitin disc diffusion method. These same 
30 isolates were confirmed for mecA gene by PCR. All strains had mecA gene. All mecA positive strains of S. aureus were tested for pvl gene. Of 200 
S. aureus, 123 (61.5%) strains were pvl positive. Among which 33 (55%) were pvl positive MRSA and 90 (64.28%) pvl positive methicillin-susceptible 
S. aureus (MSSA) strains.
Conclusion: The prevalence of the pvl among the MRSA isolates was found relatively higher in number among pus samples which indicate a possible 
key role of pvl in pathogenesis of pyogenic infections, especially skin and soft tissue infections in community setting.
Keywords: Panton–Valentine leukocidin, Cefoxitin disc diffusion method, mecA, Staphylococcus aureus, Methicillin-resistant S. aureus, methicillin-
susceptible S. aureus.
INTRODUCTION
Staphylococcus aureus is the most virulent Staphylococcus species. 
S. aureus can cause variety of infections, ranging from minor skin 
infections to post-operative wound infections. One major obstacle for 
the treatment of S. aureus infections is the development of antibiotic 
resistance in the isolates. This resistance phenomenon originated with 
penicillin, the first broad-spectrum antibiotic, which was discovered 
in the 1940s. Its adaptive power to antibiotics has resulted in the 
emergence of methicillin-resistant S. aureus (MRSA) in the beginning of 
the 1960s. Methicillin resistance is mediated by an acquired penicillin-
binding protein, PBP2a, a peptidoglycan transpeptidase encoded by 
the mecA gene that has low affinity for beta-lactams. Thus, when the 
four native peptidoglycan synthetases (penicillin-binding proteins 
1, 2, 3, and 4) are bound and inactivated by beta-lactams, PBP2a can 
still affect cell wall synthesis. mecA is harbored on the Staphylococcal 
chromosomal cassette mec (SCCmec), a genetic element that integrates 
site-specifically into the S. aureus chromosome [1].
MRSA strains are particularly serious and potentially lethal 
pathogens that possess virulence mechanisms including toxins, 
adhesions, enzymes, and immunomodulators [2]. Virulence genes 
play very important roles in bacterial pathogenesis [3] and S. aureus 
could not be an exception to this. It was in view of this that some 
of the virulence genes such as Panton–Valentine leukocidin (pvl), 
exfoliating toxin A, and toxic shock syndrome were screened for with 
the hope one of the virulence genes could be incriminated in S. aureus 
infections.
Initially, MRSA infections were observed in hospitalized patients and 
those with chronic illnesses. These types of infections are caused by 
strain of S. aureus labeled as hospital-acquired MRSA (HA-MRSA). In 
1990s, another type of MRSA strain was emerged that primarily causes 
skin and soft tissue infections in healthy people. It is called community-
acquired MRSA (CA-MRSA) [4].
Molecular characterization of SCCmec types of MRSA is very essential 
for studying the epidemiology of MRSA. This problem is further 
confounded by the recent spread of CA-MRSA and the identification 
of vancomycin-resistant MRSA. In addition to the limited treatment 
options, S. aureus strains acquire and express numerous virulence 
determinants that continue to increase its ability to cause a wide 
spectrum of human disease [5,6].
pvl is a pore-forming toxin secreted by some S. aureus strains 
which destroy leukocytes by creating pores in the mitochondrial 
membrane and associated with skin and soft tissue infections. pvl is 
a virulence factor associated with severe MRSA infections for which 
routine detection is time-consuming and dependent on the culture 
environment [7].
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Moreover, the pvl is encoded by a bi-cistronic operon known as lukF-PV/
lukS-PV gene. Epidemiologic and clinical data [8,9] provide compelling 
evidence that the high virulence potential of CA-MRSA is associated 
with the genes lukS-PV and lukF-PV encoding the subunits of the pvl and 
has also been used as an additional marker alongside SCCmec IV and V 
to classify MRSA into CA-MRSA, though not all CA-MRSA carry the pvl 
genes.
Molecular typing techniques have been used with increasing frequency 
in studies of the epidemiology of MRSA and also for rapid detection of 
MRSA clones and virulent genes also [10-12].
Community-acquired and hospital-acquired MRSA both of these contain 
mecA gene. As the mec A gene is essential for acquiring resistance 
of MRSA strains, the pvl gene is an additional factor which is seen in 
community-acquired strains [13]. Identification of mecA positive 
strains can be used as a guide for separating infected patients from 
others in hospital environment to prevent gene transfer among clinical 
strains and also the distribution of virulent factors.
Having knowledge about the prevalence of MRSA and their virulence 
factors is useful for treatment and control of community- and hospital-
acquired S. aureus infections.
Aim and objectives
To determine the association between mecA gene and pvl gene in strains 
of S. aureus isolated from hospitalized patients for grouping the MRSA 
isolates into community- and hospital-acquired MRSA genetically and 
to determine the prevalence of the pvl gene in S. aureus isolates using 
the polymerase chain reaction (PCR) technique.
METHODS
This study was the prospective type of study, carried out at Bharati 
Vidyapeeth Medical and Dental college, Sangli, Krishna Institute of 
Medical Science, Karad and Regional medical research center, ICMR, 
Regional center, Belgaum.
Inclusion criteria
A total of 200 non-repeated clinical isolates of S. aureus as per 
statistical calculation from various clinical specimens such as blood, 
pus, surgical site, wounds, sputum, tracheal aspirates, and urine were 
included in this study. Isolates were identified as S. aureus based on 
morphology, colony characteristics, and biochemical reactions as per 
the standard protocol. All clinical isolates of S. aureus confirmed by 
phenotypic tests as per Clinical Laboratory Standard Institute (CLSI) 
guideline [14,15]. Antibiotic sensitivity testing of isolates of S. aureus 
to various antimicrobial discs was carried out using Kirby-Bauer disc 
diffusion method. All antimicrobial discs were obtained from Hi-Media 
Laboratories Pvt. Ltd. Mumbai, India.
Detection of MRSA
Phenotypic method: Cefoxitin (30 ug) disc diffusion method
All testing was done according to the CLSI as well as the manufacturer’s 
recommendations. All confirmed S. aureus strains were tested for 
methicillin resistance by the Kirby-Bauer disc diffusion method using 
cefoxitin disc (30 µg) diffusion method. Zone diameters ≤19 mm were 
reported as methicillin-resistant and ≥22 mm was considered as 
methicillin sensitive [16].
Genotypic identification of MRSA (MecA-based PCR)
PCR for the detection of mecA gene is done at molecular laboratory of 
ICMR Regional center, Belgaum, by following method of Unal et al. [17]. 
Primer sequences used for mecA detection were as follows:
• 5’- AAT CTT TGT CGG TAC ACG ATATTC TTC ACG -3’
• 5’-CGT AATGAG ATT TCA GTA GAT AAT ACA ACA -3’ (Amplicon size 
310bp).
Bacterial DNA was extracted from overnight cultures of S. aureus by 
CTAB- NaCl method [18].
The quality and quantity of isolated DNA was determined using 
Nanodrop 1000 spectrophotometer (JH Biosciences, USA. Model: 
ND1000) at 260/280 nm as well as visually by horizontal gel 
electrophoresis in 1% agarose. Briefly, 1 µl of 60 ng of the extracted 
DNA was added to 24 µl of PCR amplification mix consisting of 16 µl 
of double-distilled autoclaved water, 2.5 µl of ×10 Taq buffer, 1 µl 
of 2.5 mM dNTP mix (Merck, India), 0.5 µl of 3U/µl Taq polymerase 
(Merck, India), and 0.5 mM of each primer. The mecA gene was amplified 
using the primers (Sigma, India) as described by Jonas et al., 1999 [19]. 
Amplifications were carried out in a thermal cycler (iCycler, BioRad Inc., 
USA) with conditions that consisted of 30 cycles of denaturation at 94°C 
for 45 s, annealing at 50°C for 45 s, and extension at 72°C for 1 min with 
a final extension at 72°C for 2 min. Amplicons of 310 bp were consistent 
with mecA gene amplification. The PCR products were subjected to 
agarose gel electrophoresis using gel red dye and images were acquired 
using Alpha Imager gel documentation system (JH biosciences, USA. 
Model: D E 400).
S. aureus ATCC 25923 (mecA negative) and ATCC 43300 (mecA positive) 
were used as controls for all phenotypic tests and genotypic test. The 
sensitivity and specificity of each test were calculated using the PCR 
results as a gold standard test.
Detection of pvl genes
PCR was performed on all the isolates to detect pvl gene. PCR for the 
detection of pvl gene was carried out using Cabrera et al. method [20]. 
Primer sequences used for pvl detection were as follows:
• luk-PV-1, 5’- ATC ATT AGG TAA AAT GTC TGG ACA TGA-3’
• luk-PV-2, 5’ - GCA TCA AGT GTA TTG GAT AGC AAA AGC-3’ (Amplicon 
size 433bp).
Each primer had a concentration of 1 µM while the Taq mix made up 
of the following: 10 mM of MgCl2, 0.2 mM of dNTP mix, and 1 U of Taq 
polymerase (NEB, USA). For detection of PVL gene, amplification was 
carried out with denaturation at 94°C for 30 s, annealing at 55°C for 
30 s, and extension at 72°C for 1 min for 35 cycles of amplification. The 
expected product size was 433 bp.
RESULTS
A total of 200 isolates of S. aureus from various clinical specimens 
were subjected to MRSA screening as well as to check their antibiotic 
sensitivity pattern. Maximum (61%) isolates were from pus sample and 
least from urine (5.4%). The prevalence of MRSA was different among 
various clinical specimens. Frequency of isolating MRSA was maximum 
from wound swab and pus (56.60%) specimens, followed by blood, 
fluid, and urine specimens (Graph 1).
Among all clinical samples, pus from wound infections was in highest 
number from which pvl positive MRSA was isolated.
In this study, out of 60 MRSA, 45 strains were CA-MRSA and 15 strains 
were HA-MRSA. Of 140 methicillin-susceptible S. aureus (MSSA) 
strains, 100 strains were CA-MSSA and 40 strains were HA-MSSA 
(Table 1).
Of 200 strains of S. aureus isolated in our hospital, 60 (30%) were 
identified as MRSA based on cefoxitin disc diffusion method. These same 
isolates were confirmed for mecA gene by PCR. All strains had mecA 
gene. All strains were tested for pvl gene. Of which total 123 (61.5%) 
strains were pvl positive. Among which 33 (55%) strains had both pvl 
and mecA gene and 90 (64.28%) strains had only pvl but not mecA gene 
(Table 2).
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DISCUSSION
According to the results of this study, 30% of iso lates identified as MRSA 
which were positive for mecA gene. Indian network for surveillance of 
antimicrobial resistance (INSAR) group, a multihospital-based study in 
various parts of India shown that the overall MRSA prevalence in India 
was 42% in 2008 and 40% in 2009 [21].
Our study correlates with Indian study by Mehta et al. reported 
31.8%, Vidya et al. reported 29.1%, and Kumari et al. from Nepal 
reported 26.14% prevalence of MRSA in their study [22-24]. Our MRSA 
prevalence is less than study by Dr. S. Kulakarni et al. reported higher 
incidence of 70.3% [25].
The prevalence of MRSA was different among various clinical specimens. 
Frequency of isolating MRSA was maximum from wound swab and pus 
(56.60%) specimens, followed by blood, fluid, and urine specimens. Our 
result correlates with study of Hossein et al. [26].
The occurrence of pvl gene in previous stud ies has been reported 
from 2% to 35% [27,28]. The pvl positive strains lead to infections 
with different clinical appearance even in immunocompramised 
patients lead to necrotic pneumonia, which its mortality can be as 
much as 75% [29]. Therefore, frequent monitoring of this pathogen, its 
antibiotic susceptibility and determining their virulence factors are of 
great importance in control and treatment of infections.
pvl was considered as important marker for differentiation of HA-MRSA 
and CA-MRSA. In this study, out of 145 community-associate S. aureus 
isolates, 108 strains had pvl. However, some studies have shown 
positive association of pvl genes among HA-MRSA isolates. pvl is more 
commonly seen in CA-MRSA as compared to HA-MRSA.
A study conducted by Okon et al., there was no colocalization of pvl and 
mecA genes on the genome of all the S. aureus strains examined, i.e., it 
was only possible to have pvl or mecA genes but not both genes on the 
chromosome of the S. aureus isolates [30].
Reports from various countries show the increasing prevalence of pvl 
among MRSA isolates. Kaur et al. from India, have reported overall 
62.85% of pvl prevalence among MRSA and MSSA (MRSA: 85.1% and 
MSSA: 48.8%) which indicates a higher prevalence among MRSA than 
our findings [31]. A similar study by D’Souza et al. from Mumbai, India, 
reported prevalence of 64% pvl positive isolates among MRSA [32].
A number of investigations have provided evidence that the prevalence 
of the pvl gene is high among MSSA [33].
Our findings suggested that though the prevalence of the pvl toxin 
varied in different geographical regions, in our region, the MRSA strains 
may be important reservoirs of the pvl toxin, which was now being 
slowly acquired by the MSSA strains.
CONCLUSION
We did not find any significant association of pvl gene with mecA gene. 
pvl was more associated with community-associated strains of MRSA 
and MSSA. The prevalence of the pvl among the MRSA isolates was 
found relatively higher in number among pus samples which indicate 
a possible key role of pvl in pathogenesis of pyogenic infections, 
especially skin and soft tissue infections in community setting. We can 
be concluded that the presence of pvl can be used as a reliable marker 
for CA-MRSA.
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